ICCC

NASDAQ · Biotechnology

Immucell Corp

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.24

+0.13 (+2.16%)

As of Feb 8, 2:17 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target -31.6% upside

Low Target $3.74

Average Target $4.27

High Target $6.64

Current Price $6.24

Current
$6.24

Target
$4.27

$3.74 $4.27 avg $6.64

Scenario Analysis

Bear Case

$3.74

-40.1%

Low target

Base Case

$4.27

-31.6%

Avg target

Bull Case

$6.64

+6.4%

High target

Risk/Reward

0.2x

Unfavorable

Price in Context

52-Week High

$5.45

14.5% from high

52-Week Low

$2.35

+165.5% from low

Target vs 52W High

$4.27

-21.7% vs high

Next Earnings Report

Feb 25, 2026

until earnings

Earnings in 9 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%